AbCellera Biologics Inc. (ABCL) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $42.77M | -45.4% |
| 2024 | $78.40M | +1.9% |
| 2023 | $76.95M | +8.9% |
| 2022 | $70.66M | +20.9% |
| 2021 | $58.45M | +504.3% |
| 2020 | $9.67M | +142.0% |
| 2019 | $4.00M | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $42.77M | -45.4% |
| 2024 | $78.40M | +1.9% |
| 2023 | $76.95M | +8.9% |
| 2022 | $70.66M | +20.9% |
| 2021 | $58.45M | +504.3% |
| 2020 | $9.67M | +142.0% |
| 2019 | $4.00M | — |